Abstract
Tissue factor (TF) is known to be present in a high concentration in amniotic fluid.
The main question of this study is whether tissue factor pathway inhibitor (TFPI),
a natural inhibitor of TF, is present in amniotic fluid. The study group consisted
of 28 women with normal pregnancy course, and at the first stage of termed labour.
Fifteen non-pregnant women were the control group. TF and TFPI were studied by an
immunoenzymatic method (ELISA). The level of TFPI in amniotic fluid was 38.7% of that
in blood plasma (16.81±5.34 ng/ml versus 43.41±18.70 ng/ml, P<0.001), while the level of TF in amniotic fluid was 44.8 times higher than in blood
plasma (9995.93±8533.11 pg/ml versus 252.66±28.84 pg/ml, P<0.001). Conclusions: (i) It was found, for the first time, that amniotic fluid contains TFPI (ii) It
is reasonable to assume that the intrusion of amniotic fluid into the blood-stream
may influence the plasmatic TFPI–TF equilibrium resulting in intravascular blood coagulation.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Obstetrics and Gynecology and Reproductive BiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Regulation of the extrinsic pathway system in health and disease: the role of factor VIIa and tissue factor pathway inhibitor.Thromb. Res. 1995; 79: 1-47
- Amniotic fluid embolism: analysis of the national registry.Am. J. Obstet. Gynecol. 1995; 172: 1159-1169
Bielawiec M, Radziwon P, Mazgajska K, Giedrojć J, Galar M. TF concentration and TFPI concentration and activity in healthy volunteers Haemostasis 1996;26(Suppl. 3):525 (abstract).
- Procoagulant properties of amniotic fluid.Am. J. Obstet. Gynecol. 1972; 113: 911-919
- Amniotic fluid contains tissue factor, a potent initiator of coagulation.Am. J. Obstet. Gynecol. 1991; 165: 1335-1341
- Anticoagulant properties of the vascular endothelium.Thromb. Haemost. 1997; 77: 408-423
- Human plasma extrinsic pathway inhibitor activity. I. Standardisation of assay and evolution of psychologic variables.Blood. 1989; 74: 201-206
- Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy.Thromb. Res. 1989; 55: 665-670
- Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples.Blood. 1991; 78: 387-393
- Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.Blood. 1997; 90: 944-951
- Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit.J. Clin. Invest. 1999; 103: 475-482
Shimata H, Shiotani M, Nakamura K, Ikeuchi M, Hoshino T, Komatsu T, Hatori N, Ihara Y, Sohma Y, Maeda Y, Matsuura Y, Kasakura S, Nakamura S, Kato H. The hemostatic-fibrinolytic profiles of human follicular fluid in the preovulary phase. Fibrinolysis and protolysis 1998;(suppl. 1):247 (abstract).
Article info
Publication history
Accepted:
June 23,
2000
Received in revised form:
May 26,
2000
Received:
March 23,
2000
Identification
Copyright
© 2001 Elsevier Science Ireland Ltd. Published by Elsevier Inc. All rights reserved.
